Literature DB >> 17470370

Anti-cytokine autoantibodies are ubiquitous in healthy individuals.

Masato Watanabe1, Kanji Uchida, Kazuhide Nakagaki, Hiroko Kanazawa, Bruce C Trapnell, Yoshihiko Hoshino, Hiroshi Kagamu, Hirohisa Yoshizawa, Naoto Keicho, Hajime Goto, Koh Nakata.   

Abstract

Anti-cytokine autoantibodies in healthy individuals have been widely reported but the occurrence is variable and inconstant. We hypothesized that cytokine-binding in vivo may explain their variable and infrequent detection. Therefore, we focused on the detection of the cytokine-autoantibody complexes and found that anti-cytokine autoantibody to IL-2, IL-8, tumor necrosis factor-alpha, vascular endothelial growth factor and granulocyte-colony stimulating factor were present in all 15 individuals evaluated, while those to IL-3, osteopontin and macrophage-colony stimulating factor were not detected in anyone. Autoantibodies against IL-4, IL-6, IL-10, and interferon-gamma were variously detected. Thus, we discovered that anti-cytokine autoantibodies to multiple cytokines are ubiquitous in healthy individuals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17470370     DOI: 10.1016/j.febslet.2007.04.029

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  32 in total

1.  The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline.

Authors:  Amanda G Paulovich; Jeffrey R Whiteaker; Andrew N Hoofnagle; Pei Wang
Journal:  Proteomics Clin Appl       Date:  2008-10-01       Impact factor: 3.494

2.  Response: Granulocyte/macrophage colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy persons.

Authors:  Kanji Uchida; Brenna Carey; Takuji Suzuki; Koh Nakata; Bruce Trapnell
Journal:  Blood       Date:  2010-01-14       Impact factor: 22.113

3.  Osteopontin is a tumor autoantigen in prostate cancer patients.

Authors:  Tatiana M Tilli; Eloísio A Silva; Lívia C Matos; Douglas V Faget; Bianca F P Dias; Juliana S P Vasconcelos; Yasuyuki Yokosaki; Etel R P Gimba
Journal:  Oncol Lett       Date:  2010-11-23       Impact factor: 2.967

Review 4.  Expanding the B Cell-Centric View of Systemic Lupus Erythematosus.

Authors:  Peter A Morawski; Silvia Bolland
Journal:  Trends Immunol       Date:  2017-03-06       Impact factor: 16.687

5.  Emergence of autoantibodies to HMGB1 is associated with survival in patients with septic shock.

Authors:  Stéphanie Barnay-Verdier; Lakhdar Fattoum; Chloé Borde; Srini Kaveri; Sébastien Gibot; Vincent Maréchal
Journal:  Intensive Care Med       Date:  2011-02-26       Impact factor: 17.440

Review 6.  Natural Antibodies: from First-Line Defense Against Pathogens to Perpetual Immune Homeostasis.

Authors:  Mohan S Maddur; Sébastien Lacroix-Desmazes; Jordan D Dimitrov; Michel D Kazatchkine; Jagadeesh Bayry; Srini V Kaveri
Journal:  Clin Rev Allergy Immunol       Date:  2020-04       Impact factor: 8.667

7.  Familial Association of Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Inflammatory Bowel Disease.

Authors:  Sandra S Wright; Anna Trauernicht; Erin Bonkowski; Courtney A McCall; Elizabeth A Maier; Ramona Bezold; Kathleen Lake; Claudia Chalk; Bruce C Trapnell; Mi-Ok Kim; Subra Kugathasan; Lee A Denson
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-05       Impact factor: 2.839

8.  Mining the human autoantibody repertoire: isolation of potent IL17A-neutralizing monoclonal antibodies from a patient with thymoma.

Authors:  Roger R Beerli; Monika Bauer; Andrea Fritzer; Lindsey B Rosen; Regula B Buser; Markus Hanner; Melanie Maudrich; Mario Nebenfuehr; Jorge Alejandro Sepulveda Toepfer; Susanne Mangold; Anton Bauer; Steven M Holland; Sarah K Browne; Andreas Meinke
Journal:  MAbs       Date:  2014       Impact factor: 5.857

Review 9.  Blood cytokines as biomarkers of in vivo toxicity in preclinical safety assessment: considerations for their use.

Authors:  Jacqueline M Tarrant
Journal:  Toxicol Sci       Date:  2010-05-06       Impact factor: 4.849

10.  Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects.

Authors:  Kanji Uchida; Koh Nakata; Takuji Suzuki; Maurizio Luisetti; Masato Watanabe; Diana E Koch; Carrie A Stevens; David C Beck; Lee A Denson; Brenna C Carey; Naoto Keicho; Jeffrey P Krischer; Yoshitsugu Yamada; Bruce C Trapnell
Journal:  Blood       Date:  2009-03-12       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.